| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
T2 Biosystems, Inc. (TTOO) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. TTOO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Elsbree David B | Director | Sell | 55 | $2.42 | $133.10 | -70.5% | |
| Sep 28, 2023 | Cr Group L.P. | 10% Owner | Sell | 13,130,147 | $0.17 | $2,271,957.14 | -64.7% | |
| Sep 26, 2023 | Cr Group L.P. | 10% Owner | Sell | 5,392,920 | $0.20 | $1,082,359.04 | -29.1% | |
| Sep 25, 2023 | Cr Group L.P. | 10% Owner | Sell | 250,000 | $0.25 | $62,500.00 | -1.3% | |
| Sep 22, 2023 | Cr Group L.P. | 10% Owner | Sell | 5,079,344 | $0.26 | $1,314,534.23 | -21.3% | |
| Sep 21, 2023 | Cr Group L.P. | 10% Owner | Sell | 6,338,211 | $0.30 | $1,904,632.41 | -21.0% | |
| Sep 20, 2023 | Cr Group L.P. | 10% Owner | Sell | 7,753,710 | $0.31 | $2,408,302.33 | -20.4% | |
| Sep 19, 2023 | Cr Group L.P. | 10% Owner | Sell | 10,401,466 | $0.37 | $3,806,936.56 | -21.5% | |
| Mar 28, 2023 | Gibbs Michael Terrence | General Counsel | Sell | 239 | $0.48 | $114.96 | -3.5% | |
| Feb 28, 2023 | Sprague John M | Chief Financial Officer | Sale+OE | 2,693 | $0.62 | $1,681.57 | -17.4% |